---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-26-000221"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2026-02-05T23:59:59+00:00"
generated_at: "2026-05-16T04:27:26.991637+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Artelo Biosciences gets Nasdaq panel exception to cure listing deficiencies by March 30

## Summary
- Panel granted exception to regain compliance with $2.5M stockholders' equity rule by March 30, 2026.
- Company held 2025 annual meeting on Jan 30, curing annual meeting rule deficiency previously cited by Nasdaq.
- Company previously received delist determination in Nov 2025; hearing stayed action.
- Company intends to take all reasonable measures to regain compliance, but no assurance of success.
- Failure to demonstrate compliance by March 30 could result in delisting from Nasdaq.

## SEC filing metadata
- accession: 0001640334-26-000221
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2026-02-05T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033426000221/0001640334-26-000221-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033426000221/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-26-000221
- JSON: https://secwatch.observer/filing/0001640334-26-000221.json
- Plain text: https://secwatch.observer/filing/0001640334-26-000221.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.